Around Fairweather Image
Important Dates

2012
17 January, late breaker abstract submission deadline for the 19th Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, US (website)

 

15 February, abstract submission deadline for 19th International AIDS Conference 2012, 22-27 July, Washington DC, US, (website)

5-8 March, 19th Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, US (website)

29-31 March, 16th International Workshop on HIV Observational Databases (IWHOD), Athens, Greece (website)

22-27 July, 19th International AIDS Conference 2012, Washington DC, US (website)

 

11-15 November, 11th International Congress on Drug Therapy in HIV Infection (HIV11), Glasgow, UK (website)

 




Select Language

About EuroCoord

 

EuroCoord is a Network of Excellence established by several of the biggest HIV cohorts and collaborations within Europe - CASCADE, COHERE, EuroSIDA, and PENTA.

 

This large, integrated network exploits the scientific strengths of each collaboration to ensure that the best, most competitive HIV research is performed.

 

The main advantage of this collaborative method of working is the formation of a common virtual database, which currently has access to data from over 250,000 HIV positive people from many different settings in Europe and beyond.

 

EuroCoord is made up of 23 beneficiaries chosen from 16 countries to ensure representativeness across Europe. The nature of the collaboration means that apart from these partners, there is also an associated network of numerous affiliated sites – more than 100 collaborating centres, or third parties.

 

The tasks of EuroCoord are organised into 15 different workpackages, all of which are interrelated, and unified through the scientific oversight workpackage.

 

EuroCoord is funded for a period of 5 years as part of the European Commission’s Framework Programme 7.

 

. More information about the aims of EuroCoord

. Download the EuroCoord briefing document

 

Latest News

No evidence of clinical benefit for patients starting treatment with a healthy immune system

 

A paper published by the CASCADE Collaboration in EuroCoord has found no evidence of clinical benefit for patients starting HIV treatment at higher CD4 cell counts of between 500-799 cells/mm3.

 

 

EuroCoord supports World AIDS Day

 

Thursday 1 December marks the 23rd annual World AIDS Day which is an opportunity to show support for people living with HIV, to remember those who have died, and to unite in the fight against HIV.

 

 

New guidelines will mean ‘Substantial increases’ in people requiring treatment

 

A study by the CASCADE Collaboration in EuroCoord has estimated that there will be a substantial increase in the number of HIV positive people who will require treatment within the first 5 years after becoming infected, following changes in treatment guidelines.

 

  

 
| Home Page | Site Map | Search | FAQ | Feedback | List Access Keys |